Hemastatx Overview

  • Year Founded
  • 2025

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 3

Hemastatx General Information

Description

Developer of antibody therapies designed for patients with severe and underserved bleeding disorders. The company's technology utilizes a first-in-class monoclonal antibody to block the adamts13 enzyme, enabling healthcare providers to restore von willebrand factor activity and prevent life-threatening bleeding episodes through targeted biological intervention.

Contact Information

Website
www.hemastatx.be
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Rue Clément Ader 10
  • Brussels South Charleroi BioPark
  • 6041 Charleroi
  • Belgium
Primary Industry
Biotechnology
Other Industries
Other Healthcare Services
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • Rue Clément Ader 10
  • Brussels South Charleroi BioPark
  • 6041 Charleroi
  • Belgium

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hemastatx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 01-Jun-2025 Completed Generating Revenue
2. Accelerator/Incubator 27-May-2025 Completed Generating Revenue
1. University Spin-Out 01-Jan-2025 Completed Startup
To view Hemastatx’s complete valuation and funding history, request access »

Hemastatx Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Carbon ( Belgium ) Venture Capital Minority
BaseLaunch Accelerator/Incubator Minority
KU Leuven Research & Development University
To view Hemastatx’s complete investors history, request access »

Ready to get started?

Request a free trial

Hemastatx FAQs

  • When was Hemastatx founded?

    Hemastatx was founded in 2025.

  • Where is Hemastatx headquartered?

    Hemastatx is headquartered in Charleroi, Belgium.

  • What industry is Hemastatx in?

    Hemastatx’s primary industry is Biotechnology.

  • Is Hemastatx a private or public company?

    Hemastatx is a Private company.

  • What is Hemastatx’s current revenue?

    The current revenue for Hemastatx is .

  • Who are Hemastatx’s investors?

    Carbon ( Belgium ), BaseLaunch, and KU Leuven Research & Development have invested in Hemastatx.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process